

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 5.23260671 |
| 2 | regulation of apoptotic cell clearance (GO:2000425) | 4.53566131 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.52796606 |
| 4 | protein carboxylation (GO:0018214) | 4.42905000 |
| 5 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.42905000 |
| 6 | regulation of protein activation cascade (GO:2000257) | 4.23620556 |
| 7 | regulation of complement activation (GO:0030449) | 4.18045151 |
| 8 | tyrosine metabolic process (GO:0006570) | 4.17985434 |
| 9 | plasma lipoprotein particle clearance (GO:0034381) | 4.13787698 |
| 10 | apoptotic cell clearance (GO:0043277) | 3.92169502 |
| 11 | melanin biosynthetic process (GO:0042438) | 3.87252300 |
| 12 | mannose metabolic process (GO:0006013) | 3.75842100 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 3.69563482 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 3.69126823 |
| 15 | low-density lipoprotein particle clearance (GO:0034383) | 3.68389321 |
| 16 | reverse cholesterol transport (GO:0043691) | 3.60151181 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.58720001 |
| 18 | L-phenylalanine catabolic process (GO:0006559) | 3.58720001 |
| 19 | phospholipid efflux (GO:0033700) | 3.56698470 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.54917736 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 3.54917736 |
| 22 | urea cycle (GO:0000050) | 3.51207148 |
| 23 | urea metabolic process (GO:0019627) | 3.51207148 |
| 24 | complement activation (GO:0006956) | 3.49759400 |
| 25 | melanin metabolic process (GO:0006582) | 3.41636948 |
| 26 | aromatic amino acid family catabolic process (GO:0009074) | 3.37030659 |
| 27 | secondary metabolite biosynthetic process (GO:0044550) | 3.36209445 |
| 28 | regulation of cholesterol storage (GO:0010885) | 3.33230346 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.31456389 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.31456389 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 3.31456389 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.31456389 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.31456389 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.31456389 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 3.30446149 |
| 36 | cholesterol efflux (GO:0033344) | 3.29419446 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 3.29050324 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 3.28013802 |
| 39 | positive regulation of blood coagulation (GO:0030194) | 3.26533961 |
| 40 | positive regulation of hemostasis (GO:1900048) | 3.26533961 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 3.25915999 |
| 42 | macromolecular complex remodeling (GO:0034367) | 3.25915999 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 3.25915999 |
| 44 | protein activation cascade (GO:0072376) | 3.23041378 |
| 45 | opsonization (GO:0008228) | 3.22638417 |
| 46 | kynurenine metabolic process (GO:0070189) | 3.22326179 |
| 47 | positive regulation of coagulation (GO:0050820) | 3.21167409 |
| 48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.18979914 |
| 49 | bile acid biosynthetic process (GO:0006699) | 3.18774667 |
| 50 | nitrogen cycle metabolic process (GO:0071941) | 3.16566266 |
| 51 | indolalkylamine catabolic process (GO:0046218) | 3.13786127 |
| 52 | tryptophan catabolic process (GO:0006569) | 3.13786127 |
| 53 | indole-containing compound catabolic process (GO:0042436) | 3.13786127 |
| 54 | complement activation, classical pathway (GO:0006958) | 3.11507829 |
| 55 | plasma lipoprotein particle assembly (GO:0034377) | 3.08588047 |
| 56 | low-density lipoprotein particle remodeling (GO:0034374) | 3.05301428 |
| 57 | regulation of fibrinolysis (GO:0051917) | 3.04239102 |
| 58 | tryptophan metabolic process (GO:0006568) | 3.02969299 |
| 59 | protein-lipid complex assembly (GO:0065005) | 2.98105091 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 2.96790721 |
| 61 | adhesion of symbiont to host cell (GO:0044650) | 2.95315221 |
| 62 | virion attachment to host cell (GO:0019062) | 2.95315221 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.93340747 |
| 64 | lipoprotein transport (GO:0042953) | 2.92626830 |
| 65 | fibrinolysis (GO:0042730) | 2.88740933 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 2.88026062 |
| 67 | cysteine metabolic process (GO:0006534) | 2.87668701 |
| 68 | regulation of humoral immune response (GO:0002920) | 2.82504609 |
| 69 | aldehyde catabolic process (GO:0046185) | 2.82302331 |
| 70 | plasma lipoprotein particle organization (GO:0071827) | 2.81539636 |
| 71 | glyoxylate metabolic process (GO:0046487) | 2.80892781 |
| 72 | negative regulation of sterol transport (GO:0032372) | 2.80300674 |
| 73 | negative regulation of cholesterol transport (GO:0032375) | 2.80300674 |
| 74 | regulation of triglyceride catabolic process (GO:0010896) | 2.78899844 |
| 75 | amino-acid betaine metabolic process (GO:0006577) | 2.77236536 |
| 76 | protein-lipid complex subunit organization (GO:0071825) | 2.77197817 |
| 77 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.76427985 |
| 78 | phospholipid homeostasis (GO:0055091) | 2.76218694 |
| 79 | lipoprotein metabolic process (GO:0042157) | 2.75764958 |
| 80 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.73535840 |
| 81 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.73369244 |
| 82 | adhesion of symbiont to host (GO:0044406) | 2.72643742 |
| 83 | regulation of integrin activation (GO:0033623) | 2.70777382 |
| 84 | endodermal cell differentiation (GO:0035987) | 2.70686447 |
| 85 | bile acid metabolic process (GO:0008206) | 2.69843694 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 2.68313695 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 2.68297290 |
| 88 | acute-phase response (GO:0006953) | 2.68289298 |
| 89 | triglyceride homeostasis (GO:0070328) | 2.66593955 |
| 90 | acylglycerol homeostasis (GO:0055090) | 2.66593955 |
| 91 | ketone body metabolic process (GO:1902224) | 2.65426093 |
| 92 | hemidesmosome assembly (GO:0031581) | 2.63189073 |
| 93 | skin morphogenesis (GO:0043589) | 2.61336670 |
| 94 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.59986711 |
| 95 | sterol transport (GO:0015918) | 2.58238006 |
| 96 | cholesterol transport (GO:0030301) | 2.58238006 |
| 97 | cofactor catabolic process (GO:0051187) | 2.56491673 |
| 98 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.55496139 |
| 99 | lysine catabolic process (GO:0006554) | 2.55419760 |
| 100 | lysine metabolic process (GO:0006553) | 2.55419760 |
| 101 | protein heterotrimerization (GO:0070208) | 2.55254228 |
| 102 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.55117053 |
| 103 | cellular glucuronidation (GO:0052695) | 2.54619532 |
| 104 | macrophage activation involved in immune response (GO:0002281) | 2.52355976 |
| 105 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.51387989 |
| 106 | homocysteine metabolic process (GO:0050667) | 2.51292939 |
| 107 | protein localization to endosome (GO:0036010) | 2.49510907 |
| 108 | glucuronate metabolic process (GO:0019585) | 2.48612966 |
| 109 | uronic acid metabolic process (GO:0006063) | 2.48612966 |
| 110 | barbed-end actin filament capping (GO:0051016) | 2.48598885 |
| 111 | regulation of extracellular matrix disassembly (GO:0010715) | 2.48453231 |
| 112 | ethanol oxidation (GO:0006069) | 2.47282573 |
| 113 | cell adhesion mediated by integrin (GO:0033627) | 2.45866485 |
| 114 | stress fiber assembly (GO:0043149) | 2.42949562 |
| 115 | cellular extravasation (GO:0045123) | 2.40651807 |
| 116 | negative regulation of fatty acid transport (GO:2000192) | 2.38816636 |
| 117 | basement membrane organization (GO:0071711) | 2.38765794 |
| 118 | keratan sulfate catabolic process (GO:0042340) | 2.35698434 |
| 119 | positive regulation of extracellular matrix organization (GO:1903055) | 2.29601772 |
| 120 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.29403087 |
| 121 | collagen fibril organization (GO:0030199) | 2.28054413 |
| 122 | substrate-dependent cell migration (GO:0006929) | 2.27921410 |
| 123 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.27235121 |
| 124 | cell-substrate junction assembly (GO:0007044) | 2.25127902 |
| 125 | positive regulation of receptor recycling (GO:0001921) | 2.24699996 |
| 126 | venous blood vessel morphogenesis (GO:0048845) | 2.23666033 |
| 127 | collagen metabolic process (GO:0032963) | 2.22791144 |
| 128 | extracellular matrix assembly (GO:0085029) | 2.21694565 |
| 129 | collagen catabolic process (GO:0030574) | 2.21139566 |
| 130 | extracellular matrix disassembly (GO:0022617) | 2.18478022 |
| 131 | response to muramyl dipeptide (GO:0032495) | 2.17678329 |
| 132 | cell migration involved in heart development (GO:0060973) | 2.16752666 |
| 133 | hypotonic response (GO:0006971) | 2.16435511 |
| 134 | blood vessel maturation (GO:0001955) | 2.15412873 |
| 135 | negative regulation of interleukin-8 production (GO:0032717) | 2.15131049 |
| 136 | fibril organization (GO:0097435) | 2.14974447 |
| 137 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.12837791 |
| 138 | response to laminar fluid shear stress (GO:0034616) | 2.11352543 |
| 139 | extracellular fibril organization (GO:0043206) | 2.09697742 |
| 140 | response to fluid shear stress (GO:0034405) | 2.09178453 |
| 141 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.08825400 |
| 142 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.08554496 |
| 143 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.08191791 |
| 144 | multicellular organismal catabolic process (GO:0044243) | 2.05963040 |
| 145 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.04938258 |
| 146 | lymph vessel development (GO:0001945) | 2.03988654 |
| 147 | surfactant homeostasis (GO:0043129) | 2.02054109 |
| 148 | multicellular organismal metabolic process (GO:0044236) | 2.01431237 |
| 149 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 1.99950875 |
| 150 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 1.99252022 |
| 151 | type B pancreatic cell proliferation (GO:0044342) | 1.98051083 |
| 152 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.97993454 |
| 153 | import into cell (GO:0098657) | 1.96899061 |
| 154 | negative regulation of type 2 immune response (GO:0002829) | 1.95895187 |
| 155 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.94862964 |
| 156 | cellular response to epinephrine stimulus (GO:0071872) | 1.94636462 |
| 157 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 1.94145495 |
| 158 | negative regulation of cell killing (GO:0031342) | 1.94145495 |
| 159 | semaphorin-plexin signaling pathway (GO:0071526) | 1.93726279 |
| 160 | endothelium development (GO:0003158) | 1.93402251 |
| 161 | chondroitin sulfate biosynthetic process (GO:0030206) | 1.92330157 |
| 162 | regulation of leukocyte degranulation (GO:0043300) | 1.91954690 |
| 163 | regulation of macrophage cytokine production (GO:0010935) | 1.91813973 |
| 164 | glial cell migration (GO:0008347) | 1.91548396 |
| 165 | regulation of collagen metabolic process (GO:0010712) | 1.89725753 |
| 166 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 1.89689619 |
| 167 | macroautophagy (GO:0016236) | 1.88924850 |
| 168 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.88376315 |
| 169 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 1.87454845 |
| 170 | negative regulation of granulocyte differentiation (GO:0030853) | 1.86761685 |
| 171 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 1.86643651 |
| 172 | angiogenesis involved in wound healing (GO:0060055) | 1.85195750 |
| 173 | renal filtration (GO:0097205) | 1.85102951 |
| 174 | positive regulation of histone deacetylation (GO:0031065) | 1.84543335 |
| 175 | response to manganese ion (GO:0010042) | 1.83033158 |
| 176 | pinocytosis (GO:0006907) | 1.82467514 |
| 177 | regulation of extracellular matrix organization (GO:1903053) | 1.81865204 |
| 178 | germinal center formation (GO:0002467) | 1.81856486 |
| 179 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.81597404 |
| 180 | response to peptidoglycan (GO:0032494) | 1.81550153 |
| 181 | positive regulation of cholesterol efflux (GO:0010875) | 1.81245774 |
| 182 | regulation of chemokine biosynthetic process (GO:0045073) | 1.78724476 |
| 183 | negative regulation of complement activation (GO:0045916) | 1.77677235 |
| 184 | glomerular filtration (GO:0003094) | 1.77394142 |
| 185 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 1.77144565 |
| 186 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 1.76903018 |
| 187 | membrane protein ectodomain proteolysis (GO:0006509) | 1.76769460 |
| 188 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 1.76606617 |
| 189 | regulation of mast cell degranulation (GO:0043304) | 1.75412140 |
| 190 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 1.74161692 |
| 191 | positive regulation of leukocyte degranulation (GO:0043302) | 1.73305042 |
| 192 | amyloid precursor protein catabolic process (GO:0042987) | 1.73266614 |
| 193 | extracellular matrix organization (GO:0030198) | 1.73190977 |
| 194 | interleukin-1-mediated signaling pathway (GO:0070498) | 1.73042058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.38434422 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.69070433 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.97073571 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.85951674 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.27193443 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.08300085 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.95439515 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.91726603 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.85853590 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.63708805 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.51107857 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44594042 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.40567638 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.37721525 |
| 15 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36693456 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16725496 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15733104 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.11786106 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08417273 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85865165 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77498438 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63892516 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63160274 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60766738 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58437919 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56245217 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.50444083 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44642752 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43506358 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43395211 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39574983 |
| 32 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38832950 |
| 33 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38529909 |
| 34 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38529909 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37000550 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36820982 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35776994 |
| 38 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.34176922 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33884582 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30818670 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29032260 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27937946 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.25940914 |
| 44 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.24996727 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24295600 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23865453 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.23728958 |
| 48 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.22963822 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22569644 |
| 50 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21714240 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21039932 |
| 52 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20723065 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20489207 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20171396 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19219736 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18245631 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17664338 |
| 58 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17432000 |
| 59 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17432000 |
| 60 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17206203 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16028631 |
| 62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14788024 |
| 63 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14756757 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13607284 |
| 65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13547135 |
| 66 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.12761831 |
| 67 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12553367 |
| 68 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11936074 |
| 69 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10540864 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07604606 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06622125 |
| 72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06534820 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.05260561 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03708738 |
| 75 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01977122 |
| 76 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.00326542 |
| 77 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.00325151 |
| 78 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.00325151 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99625002 |
| 80 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99561793 |
| 81 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99274697 |
| 82 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99164829 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98777308 |
| 84 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98367459 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97299474 |
| 86 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.97231717 |
| 87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96755669 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96626506 |
| 89 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95091908 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94332304 |
| 91 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94307588 |
| 92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93533209 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93520692 |
| 94 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92490466 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.92199921 |
| 96 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91252391 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90890789 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90665429 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90353997 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90180568 |
| 101 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.90008346 |
| 102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89553511 |
| 103 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89539712 |
| 104 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.89526491 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89001033 |
| 106 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.87756320 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87621731 |
| 108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86883178 |
| 109 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85494968 |
| 110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83439017 |
| 111 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83293519 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83200829 |
| 113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80457154 |
| 114 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.80095152 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79900106 |
| 116 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79104179 |
| 117 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78836213 |
| 118 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78380368 |
| 119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78124725 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78058698 |
| 121 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.77952186 |
| 122 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.77910754 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75255167 |
| 124 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.74672106 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 0.73618189 |
| 126 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73331528 |
| 127 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.72893821 |
| 128 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72088004 |
| 129 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.71691407 |
| 130 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.70875846 |
| 131 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.70400164 |
| 132 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.69859928 |
| 133 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.69241048 |
| 134 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.68090949 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67744486 |
| 136 | KDM2B_26808549_Chip-Seq_K562_Human | 0.66220552 |
| 137 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66113034 |
| 138 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66089115 |
| 139 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66046463 |
| 140 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65251903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.65827331 |
| 2 | MP0005360_urolithiasis | 4.16178068 |
| 3 | MP0009840_abnormal_foam_cell | 3.82569274 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.80971509 |
| 5 | MP0005365_abnormal_bile_salt | 3.33256897 |
| 6 | MP0005275_abnormal_skin_tensile | 3.27166051 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.98978110 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.84008884 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.79291161 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.78506694 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.73762479 |
| 12 | MP0003436_decreased_susceptibility_to | 2.51298683 |
| 13 | MP0003195_calcinosis | 2.47995184 |
| 14 | MP0000604_amyloidosis | 2.26822101 |
| 15 | MP0003303_peritoneal_inflammation | 2.21542214 |
| 16 | MP0004272_abnormal_basement_membrane | 2.19981398 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.07907802 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.06186423 |
| 19 | MP0005083_abnormal_biliary_tract | 2.03178132 |
| 20 | MP0008438_abnormal_cutaneous_collagen | 1.99977183 |
| 21 | MP0003075_altered_response_to | 1.98363882 |
| 22 | MP0006054_spinal_hemorrhage | 1.97494340 |
| 23 | MP0003690_abnormal_glial_cell | 1.95445697 |
| 24 | MP0003828_pulmonary_edema | 1.91618075 |
| 25 | MP0002419_abnormal_innate_immunity | 1.83350901 |
| 26 | MP0003724_increased_susceptibility_to | 1.82063015 |
| 27 | MP0003252_abnormal_bile_duct | 1.80937315 |
| 28 | MP0000372_irregular_coat_pigmentation | 1.80201308 |
| 29 | MP0005409_darkened_coat_color | 1.79167287 |
| 30 | MP0005332_abnormal_amino_acid | 1.75592995 |
| 31 | MP0009384_cardiac_valve_regurgitation | 1.70211340 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.67649651 |
| 33 | MP0000767_abnormal_smooth_muscle | 1.65506028 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.60709215 |
| 35 | MP0000609_abnormal_liver_physiology | 1.58300167 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.54724143 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.52036635 |
| 38 | MP0002254_reproductive_system_inflammat | 1.50251814 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.49828319 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.43823945 |
| 41 | MP0006082_CNS_inflammation | 1.41344346 |
| 42 | MP0002060_abnormal_skin_morphology | 1.40786234 |
| 43 | MP0005171_absent_coat_pigmentation | 1.37322781 |
| 44 | MP0001542_abnormal_bone_strength | 1.36106010 |
| 45 | MP0000371_diluted_coat_color | 1.35458174 |
| 46 | MP0002896_abnormal_bone_mineralization | 1.35346697 |
| 47 | MP0002933_joint_inflammation | 1.33973049 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.33449665 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33178246 |
| 50 | MP0005408_hypopigmentation | 1.31304953 |
| 51 | MP0003329_amyloid_beta_deposits | 1.29279074 |
| 52 | MP0009764_decreased_sensitivity_to | 1.28601744 |
| 53 | MP0005166_decreased_susceptibility_to | 1.28519353 |
| 54 | MP0002295_abnormal_pulmonary_circulatio | 1.28488012 |
| 55 | MP0003011_delayed_dark_adaptation | 1.28122811 |
| 56 | MP0003045_fibrosis | 1.27341174 |
| 57 | MP0005025_abnormal_response_to | 1.26778073 |
| 58 | MP0003279_aneurysm | 1.26722532 |
| 59 | MP0000343_altered_response_to | 1.24056332 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.23805486 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.23411357 |
| 62 | MP0005508_abnormal_skeleton_morphology | 1.20449202 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 1.20374717 |
| 64 | MP0001666_abnormal_nutrient_absorption | 1.19298820 |
| 65 | MP0008469_abnormal_protein_level | 1.18495653 |
| 66 | MP0004947_skin_inflammation | 1.17129664 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.16042811 |
| 68 | MP0001790_abnormal_immune_system | 1.15589070 |
| 69 | MP0005387_immune_system_phenotype | 1.15589070 |
| 70 | MP0004858_abnormal_nervous_system | 1.14867110 |
| 71 | MP0009763_increased_sensitivity_to | 1.11882941 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 1.11487849 |
| 73 | MP0005670_abnormal_white_adipose | 1.10465865 |
| 74 | MP0002090_abnormal_vision | 1.10438414 |
| 75 | MP0005257_abnormal_intraocular_pressure | 1.10387135 |
| 76 | MP0009785_altered_susceptibility_to | 1.09359173 |
| 77 | MP0008004_abnormal_stomach_pH | 1.07997174 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.06394625 |
| 79 | MP0005164_abnormal_response_to | 1.06217172 |
| 80 | MP0000751_myopathy | 1.06145744 |
| 81 | MP0001835_abnormal_antigen_presentation | 1.05258827 |
| 82 | MP0004130_abnormal_muscle_cell | 1.05107361 |
| 83 | MP0004883_abnormal_blood_vessel | 1.04743170 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.04437865 |
| 85 | MP0009643_abnormal_urine_homeostasis | 1.02618168 |
| 86 | MP0003566_abnormal_cell_adhesion | 1.02021884 |
| 87 | MP0004510_myositis | 1.01487064 |
| 88 | MP0001849_ear_inflammation | 1.01421015 |
| 89 | MP0001845_abnormal_inflammatory_respons | 1.00808284 |
| 90 | MP0000569_abnormal_digit_pigmentation | 0.98403191 |
| 91 | MP0005023_abnormal_wound_healing | 0.97001188 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.96000105 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.94295192 |
| 94 | MP0002108_abnormal_muscle_morphology | 0.93680356 |
| 95 | MP0002148_abnormal_hypersensitivity_rea | 0.92704391 |
| 96 | MP0000249_abnormal_blood_vessel | 0.91928534 |
| 97 | MP0005623_abnormal_meninges_morphology | 0.91559306 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.89682685 |
| 99 | MP0002133_abnormal_respiratory_system | 0.89039225 |
| 100 | MP0005388_respiratory_system_phenotype | 0.89039225 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.88480894 |
| 102 | MP0006138_congestive_heart_failure | 0.88293771 |
| 103 | MP0000598_abnormal_liver_morphology | 0.87975563 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.86919667 |
| 105 | MP0002452_abnormal_antigen_presenting | 0.85267341 |
| 106 | MP0000685_abnormal_immune_system | 0.84847443 |
| 107 | MP0002168_other_aberrant_phenotype | 0.84669400 |
| 108 | MP0005197_abnormal_uvea_morphology | 0.82523835 |
| 109 | MP0009278_abnormal_bone_marrow | 0.82114590 |
| 110 | MP0001958_emphysema | 0.82079938 |
| 111 | MP0001764_abnormal_homeostasis | 0.81705575 |
| 112 | MP0000858_altered_metastatic_potential | 0.81236735 |
| 113 | MP0003795_abnormal_bone_structure | 0.80726322 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.80061596 |
| 115 | MP0001324_abnormal_eye_pigmentation | 0.79054842 |
| 116 | MP0005451_abnormal_body_composition | 0.78152195 |
| 117 | MP0003448_altered_tumor_morphology | 0.78061936 |
| 118 | MP0001853_heart_inflammation | 0.77950720 |
| 119 | MP0010155_abnormal_intestine_physiology | 0.77268763 |
| 120 | MP0002405_respiratory_system_inflammati | 0.76837752 |
| 121 | MP0005390_skeleton_phenotype | 0.76303620 |
| 122 | MP0009780_abnormal_chondrocyte_physiolo | 0.76258014 |
| 123 | MP0003186_abnormal_redox_activity | 0.76151764 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.75699266 |
| 125 | MP0001851_eye_inflammation | 0.74763680 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.72642284 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.72508955 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.72403736 |
| 129 | MP0005535_abnormal_body_temperature | 0.71587156 |
| 130 | MP0001614_abnormal_blood_vessel | 0.71145277 |
| 131 | MP0005165_increased_susceptibility_to | 0.70579485 |
| 132 | MP0002971_abnormal_brown_adipose | 0.70388669 |
| 133 | MP0009697_abnormal_copulation | 0.70228823 |
| 134 | MP0003453_abnormal_keratinocyte_physiol | 0.69867708 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.69766157 |
| 136 | MP0003091_abnormal_cell_migration | 0.69662865 |
| 137 | MP0000733_abnormal_muscle_development | 0.67446454 |
| 138 | MP0002128_abnormal_blood_circulation | 0.66540910 |
| 139 | MP0001243_abnormal_dermal_layer | 0.66478161 |
| 140 | MP0005076_abnormal_cell_differentiation | 0.63696334 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.61649947 |
| 142 | MP0002113_abnormal_skeleton_development | 0.60349624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.94727517 |
| 2 | Complement deficiency (HP:0004431) | 5.61114623 |
| 3 | Abnormality of complement system (HP:0005339) | 5.16193490 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.08202941 |
| 5 | Glomerulonephritis (HP:0000099) | 4.94054392 |
| 6 | Protrusio acetabuli (HP:0003179) | 4.82619964 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.47809519 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.46859298 |
| 9 | Xanthomatosis (HP:0000991) | 4.46045991 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.44860434 |
| 11 | Premature rupture of membranes (HP:0001788) | 4.13746012 |
| 12 | Joint hemorrhage (HP:0005261) | 4.07111270 |
| 13 | * Dysostosis multiplex (HP:0000943) | 3.80973166 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.76144895 |
| 15 | Aortic aneurysm (HP:0004942) | 3.63497520 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.60220719 |
| 17 | Aortic dissection (HP:0002647) | 3.58099428 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.52724703 |
| 19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.49650153 |
| 20 | Vascular tortuosity (HP:0004948) | 3.48454722 |
| 21 | Nephritis (HP:0000123) | 3.43966052 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.39653872 |
| 23 | * Mucopolysacchariduria (HP:0008155) | 3.39492059 |
| 24 | * Urinary glycosaminoglycan excretion (HP:0003541) | 3.39492059 |
| 25 | Intrahepatic cholestasis (HP:0001406) | 3.35569964 |
| 26 | Atrophic scars (HP:0001075) | 3.28799610 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.28036591 |
| 28 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.22011013 |
| 29 | * Abnormality of polysaccharide metabolism (HP:0011012) | 3.22011013 |
| 30 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.22011013 |
| 31 | Arterial tortuosity (HP:0005116) | 3.21407640 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.17825111 |
| 33 | Myocardial infarction (HP:0001658) | 3.15938983 |
| 34 | Eczematoid dermatitis (HP:0000976) | 3.11634908 |
| 35 | Amyloidosis (HP:0011034) | 2.99067549 |
| 36 | Recurrent abscess formation (HP:0002722) | 2.94332220 |
| 37 | Follicular hyperkeratosis (HP:0007502) | 2.81184774 |
| 38 | Axonal loss (HP:0003447) | 2.80156592 |
| 39 | Hypolipoproteinemia (HP:0010981) | 2.79961491 |
| 40 | Fragile skin (HP:0001030) | 2.73044729 |
| 41 | Hypercholesterolemia (HP:0003124) | 2.70218865 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.69829263 |
| 43 | Esophageal varix (HP:0002040) | 2.69348777 |
| 44 | Peritonitis (HP:0002586) | 2.65543448 |
| 45 | Tetraparesis (HP:0002273) | 2.65036625 |
| 46 | Bladder diverticulum (HP:0000015) | 2.64874244 |
| 47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.60845031 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.60530022 |
| 49 | Abnormality of the lumbar spine (HP:0100712) | 2.60153273 |
| 50 | Recurrent bacterial skin infections (HP:0005406) | 2.59998688 |
| 51 | Hypobetalipoproteinemia (HP:0003563) | 2.57757912 |
| 52 | Epidermoid cyst (HP:0200040) | 2.54378760 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.53374204 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.52968192 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.52968192 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.52968192 |
| 57 | Genu recurvatum (HP:0002816) | 2.52404556 |
| 58 | Increased variability in muscle fiber diameter (HP:0003557) | 2.51630787 |
| 59 | Soft skin (HP:0000977) | 2.51099589 |
| 60 | Wormian bones (HP:0002645) | 2.49151158 |
| 61 | Aneurysm (HP:0002617) | 2.47570065 |
| 62 | Menorrhagia (HP:0000132) | 2.46518327 |
| 63 | Dilatation of the ascending aorta (HP:0005111) | 2.46205516 |
| 64 | Mitral stenosis (HP:0001718) | 2.42118837 |
| 65 | Hyperammonemia (HP:0001987) | 2.38267814 |
| 66 | Obstructive sleep apnea (HP:0002870) | 2.34939216 |
| 67 | Ankle contracture (HP:0006466) | 2.34852060 |
| 68 | Mitral valve prolapse (HP:0001634) | 2.34297047 |
| 69 | Blue sclerae (HP:0000592) | 2.34115736 |
| 70 | Spinal rigidity (HP:0003306) | 2.32684622 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.31682962 |
| 72 | Thoracic kyphosis (HP:0002942) | 2.23647843 |
| 73 | Type 1 muscle fiber predominance (HP:0003803) | 2.23589810 |
| 74 | Overgrowth (HP:0001548) | 2.22537077 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.21648439 |
| 76 | Cholecystitis (HP:0001082) | 2.21648439 |
| 77 | Skin nodule (HP:0200036) | 2.19272766 |
| 78 | Cervical subluxation (HP:0003308) | 2.18757963 |
| 79 | Aortic regurgitation (HP:0001659) | 2.18367589 |
| 80 | * Joint stiffness (HP:0001387) | 2.16231744 |
| 81 | Gingivitis (HP:0000230) | 2.15004303 |
| 82 | Neonatal short-limb short stature (HP:0008921) | 2.14911539 |
| 83 | Pustule (HP:0200039) | 2.14718302 |
| 84 | Upper motor neuron abnormality (HP:0002127) | 2.14708999 |
| 85 | Gingival bleeding (HP:0000225) | 2.13748331 |
| 86 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.13476419 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.12653269 |
| 88 | Abnormality of dentin (HP:0010299) | 2.10782497 |
| 89 | Ketosis (HP:0001946) | 2.10328151 |
| 90 | J-shaped sella turcica (HP:0002680) | 2.09968897 |
| 91 | Joint laxity (HP:0001388) | 2.09855384 |
| 92 | Thin bony cortex (HP:0002753) | 2.08923625 |
| 93 | Hepatocellular carcinoma (HP:0001402) | 2.08408635 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.04653133 |
| 95 | Global brain atrophy (HP:0002283) | 2.03473991 |
| 96 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03459002 |
| 97 | Turricephaly (HP:0000262) | 2.02632279 |
| 98 | Fat malabsorption (HP:0002630) | 2.02160033 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00979799 |
| 100 | Cerebral aneurysm (HP:0004944) | 1.97443513 |
| 101 | Mitral regurgitation (HP:0001653) | 1.96665788 |
| 102 | Retinal atrophy (HP:0001105) | 1.95298522 |
| 103 | Pathologic fracture (HP:0002756) | 1.94538321 |
| 104 | Hyperextensible skin (HP:0000974) | 1.93088562 |
| 105 | * Loss of speech (HP:0002371) | 1.92377127 |
| 106 | Cerebral inclusion bodies (HP:0100314) | 1.89775905 |
| 107 | Hydroxyprolinuria (HP:0003080) | 1.89519733 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 1.89519733 |
| 109 | * Ovoid vertebral bodies (HP:0003300) | 1.89244894 |
| 110 | Myositis (HP:0100614) | 1.87879916 |
| 111 | Broad face (HP:0000283) | 1.87075995 |
| 112 | Slender build (HP:0001533) | 1.86341365 |
| 113 | Abnormality of purine metabolism (HP:0004352) | 1.84551645 |
| 114 | Striae distensae (HP:0001065) | 1.84423971 |
| 115 | Aortic valve stenosis (HP:0001650) | 1.83128596 |
| 116 | Abnormality of methionine metabolism (HP:0010901) | 1.81343875 |
| 117 | Flared iliac wings (HP:0002869) | 1.80480461 |
| 118 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79891624 |
| 119 | Osteolytic defects of the hand bones (HP:0009699) | 1.79891624 |
| 120 | Infantile muscular hypotonia (HP:0008947) | 1.79726343 |
| 121 | Beaking of vertebral bodies (HP:0004568) | 1.77612070 |
| 122 | Hypoplasia of the iris (HP:0007676) | 1.77426326 |
| 123 | Peripheral demyelination (HP:0011096) | 1.77389187 |
| 124 | * Asymmetric septal hypertrophy (HP:0001670) | 1.75841756 |
| 125 | Spondylolisthesis (HP:0003302) | 1.75733661 |
| 126 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.75504696 |
| 127 | Interstitial pulmonary disease (HP:0006530) | 1.74938248 |
| 128 | Coxa vara (HP:0002812) | 1.73887003 |
| 129 | Increased connective tissue (HP:0009025) | 1.73867954 |
| 130 | Shallow orbits (HP:0000586) | 1.73284051 |
| 131 | Wide anterior fontanel (HP:0000260) | 1.72928195 |
| 132 | Disproportionate tall stature (HP:0001519) | 1.71902271 |
| 133 | Abnormality of nucleobase metabolism (HP:0010932) | 1.71123815 |
| 134 | Hand muscle atrophy (HP:0009130) | 1.70510777 |
| 135 | Vascular calcification (HP:0004934) | 1.70284556 |
| 136 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.69854364 |
| 137 | Periodontitis (HP:0000704) | 1.69520355 |
| 138 | Recurrent skin infections (HP:0001581) | 1.68242065 |
| 139 | Vertebral compression fractures (HP:0002953) | 1.67801211 |
| 140 | Supranuclear gaze palsy (HP:0000605) | 1.67768407 |
| 141 | Paraparesis (HP:0002385) | 1.67560485 |
| 142 | Blue irides (HP:0000635) | 1.66035361 |
| 143 | Broad metatarsal (HP:0001783) | 1.65541547 |
| 144 | Disinhibition (HP:0000734) | 1.65374985 |
| 145 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.65262561 |
| 146 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.65224044 |
| 147 | Long toe (HP:0010511) | 1.65049880 |
| 148 | Neuronal loss in central nervous system (HP:0002529) | 1.64684762 |
| 149 | Osteoarthritis (HP:0002758) | 1.64604863 |
| 150 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.64586900 |
| 151 | Short nail (HP:0001799) | 1.62762369 |
| 152 | Orchitis (HP:0100796) | 1.62666215 |
| 153 | Abnormality of the acetabulum (HP:0003170) | 1.61053094 |
| 154 | Emphysema (HP:0002097) | 1.60949854 |
| 155 | Hypoplasia of the odontoid process (HP:0003311) | 1.59175354 |
| 156 | Bruising susceptibility (HP:0000978) | 1.59171934 |
| 157 | Hematochezia (HP:0002573) | 1.56645496 |
| 158 | Persistence of primary teeth (HP:0006335) | 1.56158983 |
| 159 | Hypoventilation (HP:0002791) | 1.55745033 |
| 160 | Natal tooth (HP:0000695) | 1.55667492 |
| 161 | Hemorrhage of the eye (HP:0011885) | 1.53802383 |
| 162 | Cardiovascular calcification (HP:0011915) | 1.53479466 |
| 163 | Biconcave vertebral bodies (HP:0004586) | 1.53357827 |
| 164 | Pulmonary artery stenosis (HP:0004415) | 1.52606798 |
| 165 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.52083569 |
| 166 | Polycythemia (HP:0001901) | 1.52018628 |
| 167 | Stroke (HP:0001297) | 1.51827311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.79051240 |
| 2 | ERN1 | 3.77038655 |
| 3 | TRIB3 | 2.94533240 |
| 4 | CAMK1D | 2.33377559 |
| 5 | BLK | 2.25426501 |
| 6 | PKN2 | 2.11290870 |
| 7 | EPHB1 | 2.10395495 |
| 8 | RIPK1 | 2.00242912 |
| 9 | TYK2 | 1.99405455 |
| 10 | DAPK2 | 1.97269056 |
| 11 | TBK1 | 1.96897498 |
| 12 | BMX | 1.95378581 |
| 13 | RIPK4 | 1.91190765 |
| 14 | CDC42BPA | 1.87424122 |
| 15 | MET | 1.86192034 |
| 16 | CAMK1G | 1.80565312 |
| 17 | CAMKK1 | 1.79885584 |
| 18 | PRPF4B | 1.78176177 |
| 19 | TAOK3 | 1.72489176 |
| 20 | CAMKK2 | 1.72109677 |
| 21 | PTK6 | 1.71731732 |
| 22 | FGFR4 | 1.64565838 |
| 23 | TGFBR2 | 1.62290191 |
| 24 | MAP3K6 | 1.60142216 |
| 25 | EPHA3 | 1.59446201 |
| 26 | SIK1 | 1.58376249 |
| 27 | PRKD2 | 1.55185147 |
| 28 | MYLK | 1.54946229 |
| 29 | MAP3K13 | 1.52996034 |
| 30 | IRAK3 | 1.40753862 |
| 31 | JAK1 | 1.38305842 |
| 32 | FES | 1.33779830 |
| 33 | EPHB2 | 1.33623472 |
| 34 | KSR2 | 1.32583781 |
| 35 | FGR | 1.29476392 |
| 36 | CSK | 1.29042343 |
| 37 | ICK | 1.27207032 |
| 38 | MARK2 | 1.26716120 |
| 39 | PDGFRB | 1.19523494 |
| 40 | SCYL2 | 1.18470977 |
| 41 | BCKDK | 1.17185317 |
| 42 | RPS6KA2 | 1.12902282 |
| 43 | MAP3K2 | 1.12595103 |
| 44 | MAP2K3 | 1.12551706 |
| 45 | NEK9 | 1.10446359 |
| 46 | KIT | 1.09615261 |
| 47 | MAP4K1 | 1.07615821 |
| 48 | HIPK2 | 1.02751863 |
| 49 | MAP3K14 | 0.98550853 |
| 50 | TRPM7 | 0.98534226 |
| 51 | PRKCH | 0.98507793 |
| 52 | PTK2 | 0.97685801 |
| 53 | JAK2 | 0.96799428 |
| 54 | ZAP70 | 0.95763556 |
| 55 | MAP2K4 | 0.95561961 |
| 56 | NTRK1 | 0.94656811 |
| 57 | HCK | 0.94363667 |
| 58 | SGK3 | 0.92781947 |
| 59 | PIK3CG | 0.92271012 |
| 60 | MAP3K11 | 0.92258251 |
| 61 | TNK2 | 0.88518695 |
| 62 | LATS1 | 0.88401248 |
| 63 | IRAK4 | 0.88111319 |
| 64 | MAP3K9 | 0.86411040 |
| 65 | MAP3K1 | 0.85587104 |
| 66 | ABL2 | 0.84766767 |
| 67 | FGFR3 | 0.82805961 |
| 68 | MAP3K3 | 0.82512053 |
| 69 | GRK7 | 0.82453252 |
| 70 | TTN | 0.81359828 |
| 71 | TESK1 | 0.80382344 |
| 72 | MARK3 | 0.80313184 |
| 73 | MOS | 0.79686735 |
| 74 | FER | 0.77942710 |
| 75 | TAOK1 | 0.76679574 |
| 76 | ERBB4 | 0.76098984 |
| 77 | GRK6 | 0.75948558 |
| 78 | PDPK1 | 0.75914751 |
| 79 | MAPK15 | 0.74978920 |
| 80 | LRRK2 | 0.74240049 |
| 81 | KDR | 0.72386948 |
| 82 | RET | 0.71690418 |
| 83 | PRKD3 | 0.71194671 |
| 84 | IKBKE | 0.71164041 |
| 85 | PAK2 | 0.70245081 |
| 86 | TAOK2 | 0.70103509 |
| 87 | RPS6KC1 | 0.70061301 |
| 88 | RPS6KL1 | 0.70061301 |
| 89 | MAPK4 | 0.69410635 |
| 90 | MAPK12 | 0.68970069 |
| 91 | MTOR | 0.67684403 |
| 92 | MATK | 0.64885665 |
| 93 | MAP2K1 | 0.64189462 |
| 94 | TIE1 | 0.64085600 |
| 95 | IGF1R | 0.63428938 |
| 96 | PTK2B | 0.61225194 |
| 97 | RPS6KA6 | 0.60764885 |
| 98 | CSF1R | 0.60631925 |
| 99 | AKT3 | 0.60076120 |
| 100 | PRKD1 | 0.59832551 |
| 101 | MAPKAPK3 | 0.59783151 |
| 102 | DMPK | 0.58372461 |
| 103 | EGFR | 0.57480637 |
| 104 | DDR2 | 0.56906086 |
| 105 | BTK | 0.56722200 |
| 106 | ARAF | 0.52770009 |
| 107 | PDK1 | 0.52568184 |
| 108 | PDGFRA | 0.52448863 |
| 109 | PAK4 | 0.51393814 |
| 110 | MAP2K6 | 0.51296142 |
| 111 | MAPK11 | 0.51167350 |
| 112 | CDK12 | 0.50984048 |
| 113 | CDK6 | 0.50921433 |
| 114 | JAK3 | 0.50826042 |
| 115 | PAK6 | 0.50448799 |
| 116 | INSRR | 0.50417560 |
| 117 | FYN | 0.49889580 |
| 118 | STK38 | 0.49482771 |
| 119 | ITK | 0.49374636 |
| 120 | FGFR1 | 0.48545766 |
| 121 | NTRK3 | 0.48060566 |
| 122 | SGK2 | 0.46935085 |
| 123 | PRKG2 | 0.43428235 |
| 124 | GSK3A | 0.43084568 |
| 125 | LCK | 0.42989512 |
| 126 | MAPK7 | 0.41848688 |
| 127 | MAP3K7 | 0.39847215 |
| 128 | SIK2 | 0.39055107 |
| 129 | FRK | 0.38802307 |
| 130 | MINK1 | 0.37892595 |
| 131 | RPS6KA4 | 0.37297682 |
| 132 | PRKAA2 | 0.36774757 |
| 133 | LMTK2 | 0.36402267 |
| 134 | SRC | 0.36239702 |
| 135 | PRKCZ | 0.35764896 |
| 136 | FLT3 | 0.35415387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.28258595 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.56903598 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18568568 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18328869 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.61951152 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.38489683 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.38098726 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.32169361 |
| 9 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.19688189 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.11947211 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.01525922 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.82177001 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79347382 |
| 14 | * Lysosome_Homo sapiens_hsa04142 | 1.77617882 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69170677 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.65725057 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.65138416 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51440708 |
| 19 | Focal adhesion_Homo sapiens_hsa04510 | 1.48866290 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43478952 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.38616655 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.36180979 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.35234351 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32773906 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.31638857 |
| 26 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.30547653 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.30153799 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30112407 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28016999 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.25660479 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.25104365 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18263886 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17251825 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.14514088 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12546116 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.12076598 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08275079 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.05399080 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.04998768 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.03641700 |
| 41 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02246326 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02074695 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01961366 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01761995 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01670951 |
| 46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00562694 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00298485 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.00002072 |
| 49 | Malaria_Homo sapiens_hsa05144 | 0.99482332 |
| 50 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.96602096 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96411622 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95526609 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94390198 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94204869 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94147687 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93052984 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.92942635 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92542951 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90471245 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89275969 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.86162493 |
| 62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86076865 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85103525 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84326432 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84059547 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.80660484 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80602300 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80185843 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79867430 |
| 70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78965321 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77870760 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77783292 |
| 73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77744208 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75759240 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75756260 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.75417930 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75370603 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.74876124 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73505973 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72479056 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71656107 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71113790 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71070931 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.70122146 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68393730 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67991230 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.67613783 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66870130 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66569525 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64884159 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64808776 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64792592 |
| 93 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62418491 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61917174 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61783493 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61330829 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61116443 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61089451 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59715115 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59493370 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.59400639 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59263182 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58775884 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.58276728 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58096210 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57859736 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.57815394 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57809381 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57201433 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57135736 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.56705919 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56378728 |
| 113 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55995969 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55986447 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55946372 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55850868 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55406478 |
| 118 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.55189975 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55156767 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.54796140 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54151762 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52720163 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52700943 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52104305 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51212202 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50885970 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50527025 |
| 128 | Hepatitis B_Homo sapiens_hsa05161 | 0.50511938 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49810591 |
| 130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49658477 |
| 131 | Axon guidance_Homo sapiens_hsa04360 | 0.49264499 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49122509 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49078286 |
| 134 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47932470 |
| 135 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44830322 |
| 136 | Lysine degradation_Homo sapiens_hsa00310 | 0.43810638 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41626996 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41483063 |
| 139 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41007084 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40900722 |
| 141 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38561954 |
| 142 | Legionellosis_Homo sapiens_hsa05134 | 0.38122435 |
| 143 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37771945 |
| 144 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37268205 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | 0.35835659 |
| 146 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35578381 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35467024 |
| 148 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32248226 |
| 149 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32223876 |
| 150 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29932951 |
| 151 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29491219 |
| 152 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28458144 |
| 153 | Salmonella infection_Homo sapiens_hsa05132 | 0.27125814 |
| 154 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.26529663 |
| 155 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26097908 |
| 156 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24961184 |
| 157 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24644281 |
| 158 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24216653 |
| 159 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22432699 |
| 160 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.22404474 |
| 161 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.22268781 |
| 162 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.22268304 |
| 163 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.22210887 |
| 164 | Shigellosis_Homo sapiens_hsa05131 | 0.22099841 |
| 165 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.21633813 |
| 166 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20929451 |

